112
Views
209
CrossRef citations to date
0
Altmetric
Article

Regulation of SMN Protein Stability

, , , , &
Pages 1107-1115 | Received 08 Aug 2008, Accepted 08 Dec 2008, Published online: 21 Mar 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Michael D. Hebert & Aaron R. Poole. (2017) Towards an understanding of regulating Cajal body activity by protein modification. RNA Biology 14:6, pages 761-778.
Read now
S Fletcher, MI Bellgard, L Price, AP Akkari & SD Wilton. (2017) Translational development of splice-modifying antisense oligomers. Expert Opinion on Biological Therapy 17:1, pages 15-30.
Read now
Anna Kaczmarek, Svenja Schneider, Brunhilde Wirth & Markus Riessland. (2015) Investigational therapies for the treatment of spinal muscular atrophy. Expert Opinion on Investigational Drugs 24:7, pages 867-881.
Read now
Matteo Ruggiu, Vicki L. McGovern, Francesco Lotti, Luciano Saieva, Darrick K. Li, Shingo Kariya, Umrao R. Monani, Arthur H. M. Burghes & Livio Pellizzoni. (2012) A Role for SMN Exon 7 Splicing in the Selective Vulnerability of Motor Neurons in Spinal Muscular Atrophy. Molecular and Cellular Biology 32:1, pages 126-138.
Read now

Articles from other publishers (204)

Jinli Bai, Yujin Qu, Shijia OuYang, Hui Jiao, Yang Wang, Jingjing Li, Wenchen Huang, Yunlong Zhao, Xiaoyin Peng, Depeng Wang, Yuwei Jin, Hong Wang & Fang Song. (2023) Novel Alu-mediated deletions of the SMN1 gene were identified by ultra-long read sequencing technology in patients with spinal muscular atrophy. Neuromuscular Disorders 33:5, pages 382-390.
Crossref
Mandana Arbab, Zaneta Matuszek, Kaitlyn M. Kray, Ailing Du, Gregory A. Newby, Anton J. Blatnik, Aditya Raguram, Michelle F. Richter, Kevin T. Zhao, Jonathan M. Levy, Max W. ShenW. David Arnold, Dan Wang, Jun Xie, Guangping Gao, Arthur H. M. Burghes & David R. Liu. (2023) Base editing rescue of spinal muscular atrophy in cells and in mice. Science 380:6642.
Crossref
Marta Nadal, Rosa Anton, Jonatan Dorca‐Arévalo, Eva Estébanez‐Perpiñá, Eduardo F. Tizzano & Pablo Fuentes‐Prior. (2023) Structure and function analysis of Sam68 and hnRNP A1 synergy in the exclusion of exon 7 from SMN2 transcripts . Protein Science 32:4.
Crossref
Alyssa C. Hill & Jonathan Hall. (2023) The MOE Modification of RNA: Origins and Widescale Impact on the Oligonucleotide Therapeutics Field. Helvetica Chimica Acta 106:3.
Crossref
Giulietta M. Riboldi, Irene Faravelli, Paola Rinchetti & Francesco Lotti. (2023) SMN post-translational modifications in spinal muscular atrophy. Frontiers in Cellular Neuroscience 17.
Crossref
Julie Mouchet, Spyros Roumpanis, Eleni Gaki, Scott Lipnick, Maryam Oskoui, Renata S. Scalco & Basil T. Darras. (2023) Disease Burden of Spinal Muscular Atrophy: A Comparative Cohort Study Using Insurance Claims Data in the USA. Journal of Neuromuscular Diseases 10:1, pages 41-53.
Crossref
Nora Tula Detering, Tobias Schüning, Niko Hensel & Peter Claus. (2022) The phospho-landscape of the survival of motoneuron protein (SMN) protein: relevance for spinal muscular atrophy (SMA). Cellular and Molecular Life Sciences 79:9.
Crossref
Samantha A Dumas, Eric Villalón, Elizabeth M Bergman, Kenneth J Wilson, Juan J Marugan, Christian L Lorson & Barrington G Burnett. (2022) A combinatorial approach increases SMN level in SMA model mice. Human Molecular Genetics 31:17, pages 2989-3000.
Crossref
Eugenio Mercuri, Charlotte J. Sumner, Francesco Muntoni, Basil T. Darras & Richard S. Finkel. (2022) Spinal muscular atrophy. Nature Reviews Disease Primers 8:1.
Crossref
Sambee Kanda, Emily Moulton & Matthew E.R. Butchbach. (2022) Effects of Inhibitors of SLC9A-Type Sodium-Proton Exchangers on Survival Motor Neuron 2 ( SMN2 ) mRNA Splicing and Expression . Molecular Pharmacology 102:2, pages 92-105.
Crossref
Mengyao Dai, Yan Xu, Yu Sun, Bing Xiao, Xiaomin Ying, Yu Liu, Wenting Jiang, Jingmin Zhang, Xiaoqing Liu & Xing Ji. (2022) Revealing diverse alternative splicing variants of the highly homologous SMN1 and SMN2 genes by targeted long-read sequencing. Molecular Genetics and Genomics 297:4, pages 1039-1048.
Crossref
Ji-Hoon Kim, Jong-Seol Kang, Kyusang Yoo, Jinguk Jeong, Inkuk Park, Jong Ho Park, Joonwoo Rhee, Shin Jeon, Young-Woo Jo, Sang-Hyeon Hann, Minji Seo, Seungtae Moon, Soo-Jong Um, Rho Hyun Seong & Young-Yun Kong. (2022) Bap1/SMN axis in Dpp4+ skeletal muscle mesenchymal cells regulates the neuromuscular system. JCI Insight 7:10.
Crossref
Zhichao Tang, Shalakha Hegde, Junxing Zhao, Shoutian Zhu, Kristen A. Johnson, Christian L. Lorson & Jingxin Wang. (2022) CRISPR‐Mediated Enzyme Fragment Complementation Assay for Quantification of the Stability of Splice Isoforms. ChemBioChem 23:9.
Crossref
Norihisa Bizen, Asim K. Bepari, Li Zhou, Manabu Abe, Kenji Sakimura, Katsuhiko Ono & Hirohide Takebayashi. (2022) Ddx20, an Olig2 binding factor, governs the survival of neural and oligodendrocyte progenitor cells via proper Mdm2 splicing and p53 suppression. Cell Death & Differentiation 29:5, pages 1028-1041.
Crossref
Valentin Jacquier, Manon Prévot, Thierry Gostan, Rémy Bordonné, Sofia Benkhelifa-Ziyyat, Martine Barkats & Johann Soret. (2022) Splicing efficiency of minor introns in a mouse model of SMA predominantly depends on their branchpoint sequence and can involve the contribution of major spliceosome components. RNA 28:3, pages 303-319.
Crossref
Catherine E. Dominguez, David Cunningham, Akila S. Venkataramany & Dawn S. Chandler. (2022) Heat increases full-length SMN splicing: promise for splice-augmenting therapies for SMA. Human Genetics 141:2, pages 239-256.
Crossref
Emma Tabe Eko Niba, Hisahide Nishio, Yogik Onky Silvana Wijaya, Mawaddah Ar Rochmah, Toru Takarada, Atsuko Takeuchi, Tomokazu Kimizu, Kentaro Okamoto, Toshio Saito, Hiroyuki Awano, Yasuhiro Takeshima & Masakazu Shinohara. (2022) Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy. Genes 13:2, pages 205.
Crossref
Pushpa Narayanaswami & Saša Živković. 2022. Neuromuscular Disorders. Neuromuscular Disorders 225 246 .
Daniel Jutzi & Marc-David Ruepp. 2022. Alternative Splicing. Alternative Splicing 1 19 .
Alba Sansa, Ivan Hidalgo, Maria P. Miralles, Sandra de la Fuente, M. Jose Perez-Garcia, Francina Munell, Rosa M. Soler & Ana Garcera. (2021) Spinal Muscular Atrophy autophagy profile is tissue-dependent: differential regulation between muscle and motoneurons. Acta Neuropathologica Communications 9:1.
Crossref
Yuhong Zhang, Xu Chen, Qiqi Wang, Congcong Du, Wenbin Lu, Hong Yuan, Zhenzhen Zhang, Danqing Li, Xing Ling, Xiang Ren, Yang Zhao, Qi Su, Zhengcao Xing, Yuanyuan Qin, Xinyi Yang, Yajie Shen, Hongmei Wu & Yitao Qi. (2021) Hyper-SUMOylation of SMN induced by SENP2 deficiency decreases its stability and leads to spinal muscular atrophy-like pathology. Journal of Molecular Medicine 99:12, pages 1797-1813.
Crossref
Kaitlyn M. Kray, Vicki L. McGovern, Deepti Chugh, W. David Arnold & Arthur H.M. Burghes. (2021) Dual SMN inducing therapies can rescue survival and motor unit function in symptomatic ∆7SMA mice. Neurobiology of Disease 159, pages 105488.
Crossref
Gretchen Thomsen, Arthur H. M. Burghes, Caroline Hsieh, Janet Do, Binh T. T. Chu, Stephanie Perry, Basam Barkho, Petra Kaufmann, Douglas M. Sproule, Douglas E. Feltner, Wendy K. Chung, Vicki L. McGovern, Robert F. Hevner, Miriam Conces, Christopher R. Pierson, Mariacristina Scoto, Francesco Muntoni, Jerry R. Mendell & Kevin D. Foust. (2021) Biodistribution of onasemnogene abeparvovec DNA, mRNA and SMN protein in human tissue. Nature Medicine 27:10, pages 1701-1711.
Crossref
Anton J. BlatnikIIIIII, Vicki L. McGovern & Arthur H. M. Burghes. (2021) What Genetics Has Told Us and How It Can Inform Future Experiments for Spinal Muscular Atrophy, a Perspective. International Journal of Molecular Sciences 22:16, pages 8494.
Crossref
Thomas O. Crawford & Charlotte J. Sumner. (2021) Assuring long-term safety of highly effective gene-modulating therapeutics for rare diseases. Journal of Clinical Investigation 131:15.
Crossref
Gayatri Gandhi, Syahril Abdullah, Agus Iwan Foead & Wendy Wai Yeng Yeo. (2021) The potential role of miRNA therapies in spinal muscle atrophy. Journal of the Neurological Sciences 427, pages 117485.
Crossref
Matthew E. R. Butchbach. (2021) Genomic Variability in the Survival Motor Neuron Genes (SMN1 and SMN2): Implications for Spinal Muscular Atrophy Phenotype and Therapeutics Development. International Journal of Molecular Sciences 22:15, pages 7896.
Crossref
Katharina E. Meijboom, Viola Volpato, Jimena Monzón-Sandoval, Joseph M. Hoolachan, Suzan M. Hammond, Frank Abendroth, Olivier G. de Jong, Gareth Hazell, Nina Ahlskog, Matthew J.A. Wood, Caleb Webber & Melissa Bowerman. (2021) Combining multiomics and drug perturbation profiles to identify muscle-specific treatments for spinal muscular atrophy. JCI Insight 6:13.
Crossref
Nikki M. McCormack, Mahlet B. Abera, Eveline S. Arnold, Rebecca M. Gibbs, Scott E. Martin, Eugen Buehler, Yu-Chi Chen, Lu Chen, Kenneth H. Fischbeck & Barrington G. Burnett. (2021) A high-throughput genome-wide RNAi screen identifies modifiers of survival motor neuron protein. Cell Reports 35:6, pages 109125.
Crossref
Deborah L. Stabley, Jennifer Holbrook, Mena Scavina, Thomas O. Crawford, Kathryn J. Swoboda, Katherine M. Robbins & Matthew E. R. Butchbach. (2021) Detection of SMN1 to SMN2 gene conversion events and partial SMN1 gene deletions using array digital PCR. neurogenetics 22:1, pages 53-64.
Crossref
Vicki L McGovern, Kaitlyn M Kray, W David Arnold, Sandra I Duque, Chitra C Iyer, Aurélie Massoni-Laporte, Eileen Workman, Aalapi Patel, Daniel J Battle & Arthur H M Burghes. (2020) Intragenic complementation of amino and carboxy terminal SMN missense mutations can rescue Smn null mice . Human Molecular Genetics 29:21, pages 3493-3503.
Crossref
Anton J BlatnikIIIIII, Vicki L McGovern, Thanh T Le, Chitra C Iyer, Brian K Kaspar & Arthur H M Burghes. (2020) Conditional deletion of SMN in cell culture identifies functional SMN alleles. Human Molecular Genetics 29:21, pages 3477-3492.
Crossref
Megan G Pino, Kelly A Rich & Stephen J Kolb. (2021) Update on Biomarkers in Spinal Muscular Atrophy. Biomarker Insights 16, pages 117727192110356.
Crossref
Sumin Zhao, Wanyang Wang, Yaoshen Wang, Rui Han, Chunna Fan, Peixiang Ni, Fengyu Guo, Fanwei Zeng, Qiaona Yang, Yun Yang, Yan Sun, Xinhua Zhang, Yan Chen, Baosheng Zhu, Wangwei Cai, Shaoke Chen, Ren Cai, Xiaoling Guo, Chonglin Zhang, Yuqiu Zhou, Shuodan Huang, Yanhui Liu, Biyan Chen, Shanhuo Yan, Yajun Chen, Hongmei Ding, Xuan Shang, Xiangmin Xu, Jun Sun & Zhiyu Peng. (2020) NGS-based spinal muscular atrophy carrier screening of 10,585 diverse couples in China: a pan-ethnic study. European Journal of Human Genetics 29:1, pages 194-204.
Crossref
Brian K. Kaspar. 2021. Neurotherapeutics in the Era of Translational Medicine. Neurotherapeutics in the Era of Translational Medicine 49 64 .
Susanne E. Swalley & Atwood K. Cheung. 2020. Phenotypic Drug Discovery. Phenotypic Drug Discovery 140 159 .
Noam Auslander, Daniel M Ramos, Ivette Zelaya, Hiren Karathia, Thomas O. Crawford, Alejandro A Schäffer, Charlotte J Sumner & Eytan Ruppin. (2020) The GENDULF algorithm: mining transcriptomics to uncover modifier genes for monogenic diseases. Molecular Systems Biology 16:12.
Crossref
Sebastian Rademacher, Nora T. Detering, Tobias Schüning, Robert Lindner, Pamela Santonicola, Inga-Maria Wefel, Janina Dehus, Lisa M. Walter, Hella Brinkmann, Agathe Niewienda, Katharina Janek, Miguel A. Varela, Melissa Bowerman, Elia Di Schiavi & Peter Claus. (2020) A Single Amino Acid Residue Regulates PTEN-Binding and Stability of the Spinal Muscular Atrophy Protein SMN. Cells 9:11, pages 2405.
Crossref
Samantha M. Meyer, Christopher C. Williams, Yoshihiro Akahori, Toru Tanaka, Haruo Aikawa, Yuquan Tong, Jessica L. Childs-Disney & Matthew D. Disney. (2020) Small molecule recognition of disease-relevant RNA structures. Chemical Society Reviews 49:19, pages 7167-7199.
Crossref
Dylan Trundell, Stephanie Le Scouiller, Laure Le Goff, Ksenija Gorni & Carole Vuillerot. (2020) Assessment of the validity and reliability of the 32-item Motor Function Measure in individuals with Type 2 or non-ambulant Type 3 spinal muscular atrophy. PLOS ONE 15:9, pages e0238786.
Crossref
Natalia N. Singh, Eric W. Ottesen & Ravindra N. Singh. (2020) A survey of transcripts generated by spinal muscular atrophy genes. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1863:8, pages 194562.
Crossref
Patrick Lomonte, Faouzi Baklouti & Olivier Binda. (2020) The Biochemistry of Survival Motor Neuron Protein Is Paving the Way to Novel Therapies for Spinal Muscle Atrophy. Biochemistry 59:14, pages 1391-1397.
Crossref
Shiori Ando, Wataru Otsu, Daiki Osanai, Satoshi Kamiya, Kodai Ishida, Shinsuke Nakamura, Masamitsu Shimazawa & Hideaki Hara. (2020) Survival Motor Neuron Protein Modulates Lysosomal Function Through the Expression of Transcription Factor EB in Motoneurons. BPB Reports 3:4, pages 130-137.
Crossref
Annapoorna Kannan, Xiaoting Jiang, Lan He, Saif Ahmad & Laxman Gangwani. (2020) ZPR1 prevents R-loop accumulation, upregulates SMN2 expression and rescues spinal muscular atrophy. Brain 143:1, pages 69-93.
Crossref
A.J. Black, J.R. Gamarra & J. Giudice. (2019) More than a messenger: Alternative splicing as a therapeutic target. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1862:11-12, pages 194395.
Crossref
Didu S. T. Kariyawasam, Arlene D'Silva, Cindy Lin, Monique M. Ryan & Michelle A. Farrar. (2019) Biomarkers and the Development of a Personalized Medicine Approach in Spinal Muscular Atrophy. Frontiers in Neurology 10.
Crossref
Erkan Y. Osman, Madeline R. Bolding, Eric Villalón, Kevin A. Kaifer, Zachary C. Lorson, Sarah Tisdale, Yue Hao, Gavin C. Conant, J. Chris Pires, Livio Pellizzoni & Christian L. Lorson. (2019) Functional characterization of SMN evolution in mouse models of SMA. Scientific Reports 9:1.
Crossref
Maria K. Tsoumpra, Seiji Fukumoto, Toshio Matsumoto, Shin'ichi Takeda, Matthew J.A. Wood & Yoshitsugu Aoki. (2019) Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases. EBioMedicine 45, pages 630-645.
Crossref
Sandra de la Fuente, Alba Sansa, Ambika Periyakaruppiah, Ana Garcera & Rosa M. Soler. (2018) Calpain Inhibition Increases SMN Protein in Spinal Cord Motoneurons and Ameliorates the Spinal Muscular Atrophy Phenotype in Mice. Molecular Neurobiology 56:6, pages 4414-4427.
Crossref
Matthew N. Idso, Naomi R. Baxter, Sirish Narayanan, Evelyn Chang, Julia Fisher, Bradley F. Chmelka & Songi Han. (2019) Proteorhodopsin Function Is Primarily Mediated by Oligomerization in Different Micellar Surfactant Solutions. The Journal of Physical Chemistry B 123:19, pages 4180-4192.
Crossref
Annuska Strunk, Andre Abbes, Antoine Stuitje, Chris Hettinga, Eline Sepers, Reinier Snetselaar, Jan Schouten, Fay-Lynn Asselman, Inge Cuppen, Henny Lemmink, W. van der Pol & Henk Engel. (2019) Validation of a Fast, Robust, Inexpensive, Two-Tiered Neonatal Screening Test algorithm on Dried Blood Spots for Spinal Muscular Atrophy. International Journal of Neonatal Screening 5:2, pages 21.
Crossref
Valery G. Mitkovsky, Natalia Yu. Ponomareva, Vera V. Makarova, Viktoria S. Milagina, Elena N. Yampol’skaya & Andrey V. Kochetkov. (2019) Spinal muscular atrophy. Clinical and genetic examination and risk assessments in pregnancy planning (SMA) woman. Journal of Clinical Practice 10:1, pages 94-100.
Crossref
Rachel Walters, John Manion & G. Gregory Neely. (2019) Dissecting Motor Neuron Disease With Drosophila melanogaster. Frontiers in Neuroscience 13.
Crossref
Yiran Wang, Chongchong Xu, Lin Ma, Yongchao Mou, Bowen Zhang, Shanshan Zhou, Yue Tian, Jessica Trinh, Xiaoqing Zhang & Xue-Jun Li. (2019) Drug screening with human SMN2 reporter identifies SMN protein stabilizers to correct SMA pathology. Life Science Alliance 2:2, pages e201800268.
Crossref
Ye Seul SonKwangman ChoiHana LeeOhman KwonKwang Bo JungSunwha ChoJiyeon BaekBora SonSung-Min KangMingu KangJihee YoonHaihong ShenSangku LeeJung-Hwa OhHyang-Ae LeeMi-Ok LeeHyun-Soo ChoCho-Rok JungJanghwan KimSungchan ChoMi-Young Son. (2019) A SMN2 Splicing Modifier Rescues the Disease Phenotypes in an In Vitro Human Spinal Muscular Atrophy Model . Stem Cells and Development 28:7, pages 438-453.
Crossref
Corey Ruhno, Vicki L. McGovern, Matthew R. Avenarius, Pamela J. Snyder, Thomas W. Prior, Flavia C. Nery, Abdurrahman Muhtaseb, Jennifer S. Roggenbuck, John T. Kissel, Valeria A. Sansone, Jennifer J. Siranosian, Alec J. Johnstone, Pann H. Nwe, Ren Z. Zhang, Kathryn J. Swoboda & Arthur H. M. Burghes. (2019) Complete sequencing of the SMN2 gene in SMA patients detects SMN gene deletion junctions and variants in SMN2 that modify the SMA phenotype. Human Genetics 138:3, pages 241-256.
Crossref
Marilyn F. Burke, Douglas M. McLaurin, Madelyn K. Logan & Michael D. Hebert. (2019) Alteration of 28S rRNA 2′- O -methylation by etoposide correlates with decreased SMN phosphorylation and reduced Drosha levels . Biology Open.
Crossref
Chia-Yen Wu, David A. Gagnon, Juliette S. Sardin, Urva Barot, Alex Telenson, Paulo E. Arratia & Robert G. Kalb. (2018) Enhancing GABAergic Transmission Improves Locomotion in a Caenorhabditis elegans Model of Spinal Muscular Atrophy . eneuro 5:6, pages ENEURO.0289-18.2018.
Crossref
Helena Chaytow, Yu-Ting Huang, Thomas H. Gillingwater & Kiterie M. E. Faller. (2018) The role of survival motor neuron protein (SMN) in protein homeostasis. Cellular and Molecular Life Sciences 75:21, pages 3877-3894.
Crossref
Lisa M Walter, Christiane E Koch, Corinne A Betts, Nina Ahlskog, Katharina E Meijboom, Tirsa L E van Westering, Gareth Hazell, Amarjit Bhomra, Peter Claus, Henrik Oster, Matthew J A Wood & Melissa Bowerman. (2018) Light modulation ameliorates expression of circadian genes and disease progression in spinal muscular atrophy mice. Human Molecular Genetics 27:20, pages 3582-3597.
Crossref
Chitra C Iyer, Kaitlyn M Corlett, Aurélie Massoni-Laporte, Sandra I Duque, Narasimhan Madabusi, Sarah Tisdale, Vicki L McGovern, Thanh T Le, Phillip G Zaworski, W David Arnold, Livio Pellizzoni & Arthur H M Burghes. (2018) Mild SMN missense alleles are only functional in the presence of SMN2 in mammals. Human Molecular Genetics 27:19, pages 3404-3416.
Crossref
Noriko Otsuki, Reiko Arakawa, Kaori Kaneko, Ryoko Aoki, Masayuki Arakawa & Kayoko Saito. (2018) A new biomarker candidate for spinal muscular atrophy: Identification of a peripheral blood cell population capable of monitoring the level of survival motor neuron protein. PLOS ONE 13:8, pages e0201764.
Crossref
Christine E. Beattie & Stephen J. Kolb. (2018) Spinal muscular atrophy: Selective motor neuron loss and global defect in the assembly of ribonucleoproteins. Brain Research 1693, pages 92-97.
Crossref
Natalia Rodriguez-Muela, Andrey Parkhitko, Tobias Grass, Rebecca M. Gibbs, Erika M. Norabuena, Norbert Perrimon, Rajat Singh & Lee L. Rubin. (2018) Blocking p62-dependent SMN degradation ameliorates spinal muscular atrophy disease phenotypes. Journal of Clinical Investigation 128:7, pages 3008-3023.
Crossref
Anita Donlic & Amanda E. Hargrove. (2018) Targeting RNA in mammalian systems with small molecules. WIREs RNA 9:4.
Crossref
Saravanan Arumugam, Stefka Mincheva-Tasheva, Ambika Periyakaruppiah, Sandra de la Fuente, Rosa M. Soler & Ana Garcera. (2017) Regulation of Survival Motor Neuron Protein by the Nuclear Factor-Kappa B Pathway in Mouse Spinal Cord Motoneurons. Molecular Neurobiology 55:6, pages 5019-5030.
Crossref
Neelam Goyal & Pushpa Narayanaswami. (2018) Making sense of antisense oligonucleotides: A narrative review. Muscle & Nerve 57:3, pages 356-370.
Crossref
Alicia J. Angelbello, Jonathan L. Chen, Jessica L. Childs-Disney, Peiyuan Zhang, Zi-Fu Wang & Matthew D. Disney. (2018) Using Genome Sequence to Enable the Design of Medicines and Chemical Probes. Chemical Reviews 118:4, pages 1599-1663.
Crossref
Chi-Ming Wong, Lu Xu & Mabel Yau. (2018) Alternative mRNA Splicing in the Pathogenesis of Obesity. International Journal of Molecular Sciences 19:2, pages 632.
Crossref
Vanesa Lafarga, Olga Tapia, Sahil Sharma, Rocio Bengoechea, Georg Stoecklin, Miguel Lafarga & Maria T. Berciano. (2017) CBP-mediated SMN acetylation modulates Cajal body biogenesis and the cytoplasmic targeting of SMN. Cellular and Molecular Life Sciences 75:3, pages 527-546.
Crossref
Kelsey M. Gray, Kevin A. Kaifer, David Baillat, Ying Wen, Thomas R. Bonacci, Allison D. Ebert, Amanda C. Raimer, Ashlyn M. Spring, Sara ten Have, Jacqueline J. Glascock, Kushol Gupta, Gregory D. Van Duyne, Michael J. Emanuele, Angus I. Lamond, Eric J. Wagner, Christian L. Lorson & A. Gregory Matera. (2018) Self-oligomerization regulates stability of survival motor neuron protein isoforms by sequestering an SCF Slmb degron . Molecular Biology of the Cell 29:2, pages 96-110.
Crossref
Surbhi Sharma, Richard J. Young, Jingchun Chen, Xiangning Chen, Edwin C. Oh & Martin R. Schiller. (2018) Minimotifs dysfunction is pervasive in neurodegenerative disorders. Alzheimer's & Dementia: Translational Research & Clinical Interventions 4:1, pages 414-432.
Crossref
Matthew E. R. Butchbach. 2018. Systems Neuroscience. Systems Neuroscience 267 281 .
Ravindra N. Singh & Natalia N. Singh. 2018. RNA Metabolism in Neurodegenerative Diseases. RNA Metabolism in Neurodegenerative Diseases 31 61 .
Raúl Sánchez-Lanzas & José G. Castaño. (2017) Lysine-Less Variants of Spinal Muscular Atrophy SMN and SMNΔ7 Proteins Are Degraded by the Proteasome Pathway. International Journal of Molecular Sciences 18:12, pages 2667.
Crossref
Leslie C. Sutherland, Philippe Thibault, Mathieu Durand, Elvy Lapointe, Jose M. Knee, Ariane Beauvais, Irina Kalatskaya, Sarah C. Hunt, Julie J. Loiselle, Justin G. Roy, Sarah J. Tessier, Gustavo Ybazeta, Lincoln Stein, Rashmi Kothary, Roscoe Klinck & Benoit Chabot. (2017) Splicing arrays reveal novel RBM10 targets, including SMN2 pre-mRNA. BMC Molecular Biology 18:1.
Crossref
Stephen J. Kolb, Christopher S. Coffey, Jon W. Yankey, Kristin Krosschell, W. David Arnold, Seward B. Rutkove, Kathryn J. Swoboda, Sandra P. Reyna, Ai Sakonju, Basil T. Darras, Richard Shell, Nancy Kuntz, Diana Castro, Julie Parsons, Anne M. Connolly, Claudia A. Chiriboga, Craig McDonald, W. Bryan Burnette, Klaus Werner, Mathula Thangarajh, Perry B. Shieh, Erika Finanger, Merit E. Cudkowicz, Michelle M. McGovern, D. Elizabeth McNeil, Richard Finkel, Susan T. Iannaccone, Edward Kaye, Allison Kingsley, Samantha R. Renusch, Vicki L. McGovern, Xueqian Wang, Phillip G. Zaworski, Thomas W. Prior, Arthur H.M. Burghes, Amy Bartlett & John T. Kissel. (2017) Natural history of infantile‐onset spinal muscular atrophy. Annals of Neurology 82:6, pages 883-891.
Crossref
Leslie A. Nash, Emily R. McFall, Amanda M. Perozzo, Maddison Turner, Kathy L. Poulin, Yves De Repentigny, Joseph K. Burns, Hugh J. McMillan, Jodi Warman Chardon, Dylan Burger, Rashmi Kothary & Robin J. Parks. (2017) Survival Motor Neuron Protein is Released from Cells in Exosomes: A Potential Biomarker for Spinal Muscular Atrophy. Scientific Reports 7:1.
Crossref
N N Singh, M D Howell, E J Androphy & R N Singh. (2017) How the discovery of ISS-N1 led to the first medical therapy for spinal muscular atrophy. Gene Therapy 24:9, pages 520-526.
Crossref
Jimmy Rodriguez Murillo, Livia Goto-Silva, Aniel Sánchez, Fábio C.S. Nogueira, Gilberto B. Domont & Magno Junqueira. (2017) Quantitative proteomic analysis identifies proteins and pathways related to neuronal development in differentiated SH-SY5Y neuroblastoma cells. EuPA Open Proteomics 16, pages 1-11.
Crossref
Catherine E. Dominguez, David Cunningham & Dawn S. Chandler. (2017) SMN regulation in SMA and in response to stress: new paradigms and therapeutic possibilities. Human Genetics 136:9, pages 1173-1191.
Crossref
Vittoria Pagliarini, Piergiorgio La Rosa & Claudio Sette. (2017) Faulty RNA splicing: consequences and therapeutic opportunities in brain and muscle disorders. Human Genetics 136:9, pages 1215-1235.
Crossref
Matthew D. Howell, Eric W. Ottesen, Natalia N. Singh, Rachel L. Anderson, Joonbae Seo, Senthilkumar Sivanesan, Elizabeth M. Whitley & Ravindra N. Singh. (2017) TIA1 is a gender-specific disease modifier of a mild mouse model of spinal muscular atrophy. Scientific Reports 7:1.
Crossref
Toru Takarada, Mawaddah Ar Rochmah, Nur Imma Fatimah Harahap, Masakazu Shinohara, Toshio Saito, Kayoko Saito, Poh San Lai, Yoshihiro Bouike, Yasuhiro Takeshima, Hiroyuki Awano, Ichiro Morioka, Kazumoto Iijima, Hisahide Nishio & Atsuko Takeuchi. (2017) SMA mutations in SMN Tudor and C-terminal domains destabilize the protein. Brain and Development 39:7, pages 606-612.
Crossref
Xingxing Wu, Shu-Huei Wang, Junjie Sun, Adrian R Krainer, Yimin Hua & Thomas W Prior. (2017) A-44G transition in SMN2 intron 6 protects patients with spinal muscular atrophy. Human Molecular Genetics 26:14, pages 2768-2780.
Crossref
Cinsley Gentillon, Andrew J. Connell, Ryan W. Kirk & Matthew E. R. Butchbach. (2017) The effects of C5-substituted 2,4-diaminoquinazolines on selected transcript expression in spinal muscular atrophy cells. PLOS ONE 12:6, pages e0180657.
Crossref
Maia Lanfranco, Neville Vassallo & Ruben J. Cauchi. (2017) Spinal Muscular Atrophy: From Defective Chaperoning of snRNP Assembly to Neuromuscular Dysfunction. Frontiers in Molecular Biosciences 4.
Crossref
Anne Rietz, Hongxia Li, Kevin M. Quist, Jonathan J. Cherry, Christian L. Lorson, Barrington G. Burnett, Nicholas L. Kern, Alyssa N. Calder, Melanie Fritsche, Hrvoje Lusic, Patrick J. Boaler, Sungwoon Choi, Xuechao Xing, Marcie A. Glicksman, Gregory D. Cuny, Elliot J. Androphy & Kevin J. Hodgetts. (2017) Discovery of a Small Molecule Probe That Post-Translationally Stabilizes the Survival Motor Neuron Protein for the Treatment of Spinal Muscular Atrophy. Journal of Medicinal Chemistry 60:11, pages 4594-4610.
Crossref
Matthew D. Howell, Eric W. Ottesen, Natalia N. Singh, Rachel L. Anderson & Ravindra N. Singh. (2017) Gender-Specific Amelioration of SMA Phenotype upon Disruption of a Deep Intronic Structure by an Oligonucleotide. Molecular Therapy 25:6, pages 1328-1341.
Crossref
Joseph R. Wooley, Melissa E. Crowder, Noah J. Pyles & Charlotte J. Sumner. 2017. Neurodegeneration. Neurodegeneration 179 201 .
Mohini JangiChristina FleetPatrick CullenShipra V. GuptaShila MekhoubadEric ChiaoNorm AllaireC. Frank BennettFrank RigoAdrian R. KrainerJessica A. HurtJohn P. CarulliJohn F. Staropoli. (2017) SMN deficiency in severe models of spinal muscular atrophy causes widespread intron retention and DNA damage. Proceedings of the National Academy of Sciences 114:12.
Crossref
Ravindra N. Singh, Matthew D. Howell, Eric W. Ottesen & Natalia N. Singh. (2017) Diverse role of survival motor neuron protein. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1860:3, pages 299-315.
Crossref
J.J. Cherry, A.N. Calder, K.J. Hodgetts & E.J. Androphy. 2017. Spinal Muscular Atrophy. Spinal Muscular Atrophy 283 299 .
A.H.M. Burghes, C.J. DiDonato, V.L. McGovern & W.D. Arnold. 2017. Spinal Muscular Atrophy. Spinal Muscular Atrophy 241 260 .
B. Wirth, N. Mendoza-Ferreira & L. Torres-Benito. 2017. Spinal Muscular Atrophy. Spinal Muscular Atrophy 191 210 .
B.R. So, Z. Zhang & G. Dreyfuss. 2017. Spinal Muscular Atrophy. Spinal Muscular Atrophy 99 111 .
N.N. Singh, M.D. Howell & R.N. Singh. 2017. Spinal Muscular Atrophy. Spinal Muscular Atrophy 75 97 .
A.H.M. Burghes & V.L. McGovern. 2017. Molecular and Cellular Therapies for Motor Neuron Diseases. Molecular and Cellular Therapies for Motor Neuron Diseases 121 139 .
Matthew G. Woll, Nikolai A. Naryshkin & Gary M. Karp. 2018. RNA Therapeutics. RNA Therapeutics 135 176 .
Pavithra M. Dedigama-Arachchige & Mary Kay H. Pflum. (2016) K-CLASP: A Tool to Identify Phosphosite Specific Kinases and Interacting Proteins. ACS Chemical Biology 11:12, pages 3251-3255.
Crossref
W. David Arnold, Sandra Duque, Chitra C. Iyer, Phillip Zaworski, Vicki L. McGovern, Shannon J. Taylor, Katharine M. von Herrmann, Dione T. Kobayashi, Karen S. Chen, Stephen J. Kolb, Sergey V. Paushkin & Arthur H. M. Burghes. (2016) Normalization of Patient-Identified Plasma Biomarkers in SMNΔ7 Mice following Postnatal SMN Restoration. PLOS ONE 11:12, pages e0167077.
Crossref
Alyssa N. Calder, Elliot J. Androphy & Kevin J. Hodgetts. (2016) Small Molecules in Development for the Treatment of Spinal Muscular Atrophy. Journal of Medicinal Chemistry 59:22, pages 10067-10083.
Crossref
Mahlet B. Abera, Jingbo Xiao, Jonathan Nofziger, Steve Titus, Noel Southall, Wei Zheng, Kasey E. Moritz, Marc Ferrer, Jonathan J. Cherry, Elliot J. Androphy, Amy Wang, Xin Xu, Christopher Austin, Kenneth H. Fischbeck, Juan J. Marugan & Barrington G. Burnett. (2016) ML372 blocks SMN ubiquitination and improves spinal muscular atrophy pathology in mice. JCI Insight 1:19.
Crossref
Philipp Odermatt, Judith Trüb, Lavinia Furrer, Roger Fricker, Andreas Marti & Daniel Schümperli. (2016) Somatic Therapy of a Mouse SMA Model with a U7 snRNA Gene Correcting SMN2 Splicing. Molecular Therapy 24:10, pages 1797-1805.
Crossref
Joseph K. Burns, Rashmi Kothary & Robin J. Parks. (2016) Opening the window: The case for carrier and perinatal screening for spinal muscular atrophy. Neuromuscular Disorders 26:9, pages 551-559.
Crossref
Ambika Periyakaruppiah, Sandra de la Fuente, Saravanan Arumugam, Núria Bahí, Ana Garcera & Rosa M. Soler. (2016) Autophagy modulators regulate survival motor neuron protein stability in motoneurons. Experimental Neurology 283, pages 287-297.
Crossref
Rocío Tejero, Mario Lopez-Manzaneda, Saravanan Arumugam & Lucía Tabares. (2016) Synaptotagmin-2, and -1, linked to neurotransmission impairment and vulnerability in Spinal Muscular Atrophy. Human Molecular Genetics, pages ddw297.
Crossref
Rachael A. Powis, Evangelia Karyka, Penelope Boyd, Julien Côme, Ross A. Jones, Yinan Zheng, Eva Szunyogova, Ewout J.N. Groen, Gillian Hunter, Derek Thomson, Thomas M. Wishart, Catherina G. Becker, Simon H. Parson, Cécile Martinat, Mimoun Azzouz & Thomas H. Gillingwater. (2016) Systemic restoration of UBA1 ameliorates disease in spinal muscular atrophy. JCI Insight 1:11.
Crossref
Matthew G. Woll, Hongyan Qi, Anthony Turpoff, Nanjing Zhang, Xiaoyan Zhang, Guangming Chen, Chunshi Li, Song Huang, Tianle Yang, Young-Choon Moon, Chang-Sun Lee, Soongyu Choi, Neil G. Almstead, Nikolai A. Naryshkin, Amal Dakka, Jana Narasimhan, Vijayalakshmi Gabbeta, Ellen Welch, Xin Zhao, Nicole Risher, Josephine Sheedy, Marla Weetall & Gary M. Karp. (2016) Discovery and Optimization of Small Molecule Splicing Modifiers of Survival Motor Neuron 2 as a Treatment for Spinal Muscular Atrophy. Journal of Medicinal Chemistry 59:13, pages 6070-6085.
Crossref
Xin Zhao, Zhihua Feng, Karen K. Y. Ling, Anna Mollin, Josephine Sheedy, Shirley Yeh, Janet Petruska, Jana Narasimhan, Amal Dakka, Ellen M. Welch, Gary Karp, Karen S. Chen, Friedrich Metzger, Hasane Ratni, Francesco Lotti, Sarah Tisdale, Nikolai A. Naryshkin, Livio Pellizzoni, Sergey Paushkin, Chien-Ping Ko & Marla Weetall. (2016) Pharmacokinetics, pharmacodynamics, and efficacy of a small-molecule SMN2 splicing modifier in mouse models of spinal muscular atrophy . Human Molecular Genetics 25:10, pages 1885-1899.
Crossref
Gabriel Sanchez, Emma Bondy-Chorney, Janik Laframboise, Geneviève Paris, Andréanne Didillon, Bernard J. Jasmin & Jocelyn Côté. (2016) A novel role for CARM1 in promoting nonsense-mediated mRNA decay: potential implications for spinal muscular atrophy. Nucleic Acids Research 44:6, pages 2661-2676.
Crossref
Ke-Jun Han, Daniel Foster, Edward W. Harhaj, Monika Dzieciatkowska, Kirk Hansen & Chang-Wei Liu. (2016) Monoubiquitination of survival motor neuron regulates its cellular localization and Cajal body integrity. Human Molecular Genetics 25:7, pages 1392-1405.
Crossref
Matthew E. R. Butchbach. (2016) Copy Number Variations in the Survival Motor Neuron Genes: Implications for Spinal Muscular Atrophy and Other Neurodegenerative Diseases. Frontiers in Molecular Biosciences 3.
Crossref
Phillip Zaworski, Katharine M. von Herrmann, Shannon Taylor, Sara S. Sunshine, Kathleen McCarthy, Nicole Risher, Tara Newcomb, Marla Weetall, Thomas W. Prior, Kathryn J. Swoboda, Karen S. Chen & Sergey Paushkin. (2016) SMN Protein Can Be Reliably Measured in Whole Blood with an Electrochemiluminescence (ECL) Immunoassay: Implications for Clinical Trials. PLOS ONE 11:3, pages e0150640.
Crossref
Stephen J. Kolb, Christopher S. Coffey, Jon W. Yankey, Kristin Krosschell, W. David Arnold, Seward B. Rutkove, Kathryn J. Swoboda, Sandra P. Reyna, Ai Sakonju, Basil T. Darras, Richard Shell, Nancy Kuntz, Diana Castro, Susan T. Iannaccone, Julie Parsons, Anne M. Connolly, Claudia A. Chiriboga, Craig McDonald, W. Bryan Burnette, Klaus Werner, Mathula Thangarajh, Perry B. Shieh, Erika Finanger, Merit E. Cudkowicz, Michelle M. McGovern, D. Elizabeth McNeil, Richard Finkel, Edward Kaye, Allison Kingsley, Samantha R. Renusch, Vicki L. McGovern, Xueqian Wang, Phillip G. Zaworski, Thomas W. Prior, Arthur H.M. Burghes, Amy Bartlett & John T. Kissel. (2016) Baseline results of the Neuro NEXT spinal muscular atrophy infant biomarker study . Annals of Clinical and Translational Neurology 3:2, pages 132-145.
Crossref
Saif AhmadKanchan BhatiaAnnapoorna KannanLaxman Gangwani. (2016) Molecular Mechanisms of Neurodegeneration in Spinal Muscular Atrophy. Journal of Experimental Neuroscience 10, pages JEN.S33122.
Crossref
Nur Imma Fatimah Harahap, Dian Kesumapramudya Nurputra, Mawaddah Ar Rochmah, Ai Shima, Naoya Morisada, Toru Takarada, Atsuko Takeuchi, Yumi Tohyama, Shinichiro Yanagisawa & Hisahide Nishio. (2015) Salbutamol inhibits ubiquitin-mediated survival motor neuron protein degradation in spinal muscular atrophy cells. Biochemistry and Biophysics Reports 4, pages 351-356.
Crossref
Dairong Feng, Yi Cheng, Yan Meng, Liping Zou, Shangzhi Huang & Jiuyong Xie. (2015) Multiple effects of curcumin on promoting expression of the exon 7-containing SMN2 transcript. Genes & Nutrition 10:6.
Crossref
Vittoria Pagliarini, Laura Pelosi, Maria Blaire Bustamante, Annalisa Nobili, Maria Grazia Berardinelli, Marcello D’Amelio, Antonio Musarò & Claudio Sette. (2015) SAM68 is a physiological regulator of SMN2 splicing in spinal muscular atrophy . Journal of Cell Biology 211:1, pages 77-90.
Crossref
Vicki L. McGovern, Chitra C. Iyer, W. David Arnold, Sara E. Gombash, Phillip G. Zaworski, Anton J. BlatnikIIIIII, Kevin D. Foust & Arthur H.M. Burghes. (2015) SMN expression is required in motor neurons to rescue electrophysiological deficits in the SMNΔ7 mouse model of SMA. Human Molecular Genetics 24:19, pages 5524-5541.
Crossref
Natalia N Singh, Brian M Lee, Christine J DiDonato & Ravindra N Singh. (2015) Mechanistic principles of antisense targets for the treatment of spinal muscular atrophy. Future Medicinal Chemistry 7:13, pages 1793-1808.
Crossref
Andrea Luchetti, Silvia Ciafrè, Michela Murdocca, Arianna Malgieri, Andrea Masotti, Massimo Sanchez, Maria Farace, Giuseppe Novelli & Federica Sangiuolo. (2015) A Perturbed MicroRNA Expression Pattern Characterizes Embryonic Neural Stem Cells Derived from a Severe Mouse Model of Spinal Muscular Atrophy (SMA). International Journal of Molecular Sciences 16:8, pages 18312-18327.
Crossref
Denise Locatelli, Mineko Terao, Mami Kurosaki, Maria Clara Zanellati, Daniela Rita Pletto, Adele Finardi, Francesca Colciaghi, Enrico Garattini & Giorgio Stefano Battaglia. (2015) Different Stability and Proteasome-Mediated Degradation Rate of SMN Protein Isoforms. PLOS ONE 10:7, pages e0134163.
Crossref
Huisheng Liu, Jianfeng Lu, Hong Chen, Zhongwei Du, Xue-Jun Li & Su-Chun Zhang. (2015) Spinal muscular atrophy patient-derived motor neurons exhibit hyperexcitability. Scientific Reports 5:1.
Crossref
Vicki L. McGovern, Aurélie Massoni-Laporte, Xueyong Wang, Thanh T. Le, Hao T. Le, Christine E. Beattie, Mark M. Rich & Arthur H. M. Burghes. (2015) Plastin 3 Expression Does Not Modify Spinal Muscular Atrophy Severity in the ∆7 SMA Mouse. PLOS ONE 10:7, pages e0132364.
Crossref
James Palacino, Susanne E Swalley, Cheng Song, Atwood K Cheung, Lei Shu, Xiaolu Zhang, Mailin Van Hoosear, Youngah Shin, Donovan N Chin, Caroline Gubser Keller, Martin Beibel, Nicole A Renaud, Thomas M Smith, Michael Salcius, Xiaoying Shi, Marc Hild, Rebecca Servais, Monish Jain, Lin Deng, Caroline Bullock, Michael McLellan, Sven Schuierer, Leo Murphy, Marcel J J Blommers, Cecile Blaustein, Frada Berenshteyn, Arnaud Lacoste, Jason R Thomas, Guglielmo Roma, Gregory A Michaud, Brian S Tseng, Jeffery A Porter, Vic E Myer, John A Tallarico, Lawrence G Hamann, Daniel Curtis, Mark C Fishman, William F Dietrich, Natalie A Dales & Rajeev Sivasankaran. (2015) SMN2 splice modulators enhance U1–pre-mRNA association and rescue SMA mice. Nature Chemical Biology 11:7, pages 511-517.
Crossref
Deborah L. Stabley, Ashlee W. Harris, Jennifer Holbrook, Nicholas J. Chubbs, Kevin W. Lozo, Thomas O. Crawford, Kathryn J. Swoboda, Vicky L. Funanage, Wenlan Wang, William Mackenzie, Mena Scavina, Katia Sol‐Church & Matthew E. R. Butchbach. (2015) SMN1 and SMN2 copy numbers in cell lines derived from patients with spinal muscular atrophy as measured by array digital PCR . Molecular Genetics & Genomic Medicine 3:4, pages 248-257.
Crossref
Monica Nizzardo, Chiara Simone, Sara Dametti, Sabrina Salani, Gianna Ulzi, Serena Pagliarani, Federica Rizzo, Emanuele Frattini, Franco Pagani, Nereo Bresolin, Giacomo Comi & Stefania Corti. (2015) Spinal muscular atrophy phenotype is ameliorated in human motor neurons by SMN increase via different novel RNA therapeutic approaches. Scientific Reports 5:1.
Crossref
Irene Faravelli, Monica Nizzardo, Giacomo P. Comi & Stefania Corti. (2015) Spinal muscular atrophy—recent therapeutic advances for an old challenge. Nature Reviews Neurology 11:6, pages 351-359.
Crossref
Chenda O. Seng, Craig Magee, Philip J. Young, Christian L. Lorson & James P. Allen. (2015) Retracted: The SMN structure reveals its crucial role in snRNP assembly. Human Molecular Genetics 24:8, pages 2138-2146.
Crossref
Constantin d’Ydewalle & Charlotte J. Sumner. (2015) Spinal Muscular Atrophy Therapeutics: Where do we Stand?. Neurotherapeutics 12:2, pages 303-316.
Crossref
Kathrin Meyer, Laura Ferraiuolo, Leah Schmelzer, Lyndsey Braun, Vicki McGovern, Shibi Likhite, Olivia Michels, Alessandra Govoni, Julie Fitzgerald, Pablo Morales, Kevin D Foust, Jerry R Mendell, Arthur H M Burghes & Brian K Kaspar. (2015) Improving Single Injection CSF Delivery of AAV9-mediated Gene Therapy for SMA: A Dose–response Study in Mice and Nonhuman Primates. Molecular Therapy 23:3, pages 477-487.
Crossref
Sandra I. Duque, W. David Arnold, Philipp Odermatt, Xiaohui Li, Paul N. Porensky, Leah Schmelzer, Kathrin Meyer, Stephen J. Kolb, Daniel Schümperli, Brian K. Kaspar & Arthur H. M. Burghes. (2015) A large animal model of spinal muscular atrophy and correction of phenotype. Annals of Neurology 77:3, pages 399-414.
Crossref
Matthew J. Walsh, Johnathan Cooper-Knock, Jennifer E. Dodd, Matthew J. Stopford, Simeon R. Mihaylov, Janine Kirby, Pamela J. Shaw & Guillaume M. Hautbergue. (2015) Invited Review: Decoding the pathophysiological mechanisms that underlie RNA dysregulation in neurodegenerative disorders: a review of the current state of the art. Neuropathology and Applied Neurobiology 41:2, pages 109-134.
Crossref
W. David Arnold, Darine Kassar & John T. Kissel. (2015) Spinal muscular atrophy: Diagnosis and management in a new therapeutic era. Muscle & Nerve 51:2, pages 157-167.
Crossref
Sean G. Mack, Daniel J. Cook, Prasad Dhurjati & Matthew E. R. Butchbach. (2014) Systems Biology Investigation of cAMP Modulation to Increase SMN Levels for the Treatment of Spinal Muscular Atrophy. PLoS ONE 9:12, pages e115473.
Crossref
Rachael A. Powis, Chantal A. Mutsaers, Thomas. M. Wishart, Gillian Hunter, Brunhilde Wirth & Thomas H. Gillingwater. (2014) Increased levels of UCHL1 are a compensatory response to disrupted ubiquitin homeostasis in spinal muscular atrophy and do not represent a viable therapeutic target. Neuropathology and Applied Neurobiology 40:7, pages 873-887.
Crossref
Eman BadrLenwood S. Heath. (2014) Identifying Splicing Regulatory Elements with de Bruijn Graphs. Journal of Computational Biology 21:12, pages 880-897.
Crossref
Katherine V. Bricceno, Tara Martinez, Evgenia Leikina, Stephanie Duguez, Terence A. Partridge, Leonid V. Chernomordik, Kenneth H. Fischbeck, Charlotte J. Sumner & Barrington G. Burnett. (2014) Survival motor neuron protein deficiency impairs myotube formation by altering myogenic gene expression and focal adhesion dynamics. Human Molecular Genetics 23:18, pages 4745-4757.
Crossref
K. L. Robbins, J. J. Glascock, E. Y. Osman, M. R. Miller & C. L. Lorson. (2014) Defining the therapeutic window in a severe animal model of spinal muscular atrophy. Human Molecular Genetics 23:17, pages 4559-4568.
Crossref
Kavita Praveen, Ying Wen, Kelsey M. Gray, John J. Noto, Akash R. Patlolla, Gregory D. Van Duyne & A. Gregory Matera. (2014) SMA-Causing Missense Mutations in Survival motor neuron (Smn) Display a Wide Range of Phenotypes When Modeled in Drosophila. PLoS Genetics 10:8, pages e1004489.
Crossref
Graham M. Wynne & Angela J. Russell. 2014. Orphan Drugs and Rare Diseases. Orphan Drugs and Rare Diseases 257 343 .
Nikolai A. NaryshkinMarla WeetallAmal DakkaJana NarasimhanXin ZhaoZhihua FengKaren K. Y. LingGary M. KarpHongyan QiMatthew G. WollGuangming ChenNanjing ZhangVijayalakshmi GabbetaPriya VaziraniAnuradha BhattacharyyaBansri FuriaNicole RisherJosephine SheedyRonald KongJiyuan MaAnthony TurpoffChang-Sun LeeXiaoyan ZhangYoung-Choon MoonPanayiota TrifillisEllen M. WelchJoseph M. ColacinoJohn BabiakNeil G. AlmsteadStuart W. PeltzLoren A. EngKaren S. ChenJesse L. MullMaureen S. LynesLee L. RubinPaulo FontouraLuca SantarelliDaniel HaehnkeKathleen D. McCarthyRoland SchmuckiMartin EbelingManaswini SivaramakrishnanChien-Ping KoSergey V. PaushkinHasane RatniIrene GerlachAnirvan GhoshFriedrich Metzger. (2014) SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy . Science 345:6197, pages 688-693.
Crossref
Jonathan J. CherryDione T. KobayashiMaureen M. LynesNikolai N. NaryshkinFrancesco Danilo TizianoPhillip G. ZaworskiLee L. RubinJill Jarecki. (2014) Assays for the Identification and Prioritization of Drug Candidates for Spinal Muscular Atrophy. ASSAY and Drug Development Technologies 12:6, pages 315-341.
Crossref
Matthew D Howell, Natalia N Singh & Ravindra N Singh. (2014) Advances in therapeutic development for spinal muscular atrophy. Future Medicinal Chemistry 6:9, pages 1081-1099.
Crossref
Sunghee Cho, Heegyum Moon, Tiing Jen Loh, Hyun Kyung Oh, Darren Reese Williams, D. Joshua Liao, Jianhua Zhou, Michael R. Green, Xuexiu Zheng & Haihong Shen. (2014) PSF contacts exon 7 of SMN2 pre-mRNA to promote exon 7 inclusion. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1839:6, pages 517-525.
Crossref
Chitra C. Iyer, Vicki L. McGovern, Dawnne O. Wise, David J. Glass & Arthur H.M. Burghes. (2014) Deletion of atrophy enhancing genes fails to ameliorate the phenotype in a mouse model of spinal muscular atrophy. Neuromuscular Disorders 24:5, pages 436-444.
Crossref
Thomas M. Wishart, Chantal A. Mutsaers, Markus Riessland, Michell M. Reimer, Gillian Hunter, Marie L. Hannam, Samantha L. Eaton, Heidi R. Fuller, Sarah L. Roche, Eilidh Somers, Robert Morse, Philip J. Young, Douglas J. Lamont, Matthias Hammerschmidt, Anagha Joshi, Peter Hohenstein, Glenn E. Morris, Simon H. Parson, Paul A. Skehel, Thomas Becker, Iain M. Robinson, Catherina G. Becker, Brunhilde Wirth & Thomas H. Gillingwater. (2014) Dysregulation of ubiquitin homeostasis and β-catenin signaling promote spinal muscular atrophy. Journal of Clinical Investigation 124:4, pages 1821-1834.
Crossref
Modibo Sangaré, Brant Hendrickson, Hammadoun Ali Sango, Kelian Chen, Jonathan Nofziger, Abdelbasset Amara, Amalia Dutra, Alice B. Schindler, Aldiouma Guindo, Mahamadou Traoré, George Harmison, Evgenia Pak, Fatoumata N'Go Yaro, Katherine Bricceno, Christopher Grunseich, Guibin Chen, Manfred Boehm, Kristen Zukosky, Nouhoum Bocoum, Katherine G. Meilleur, Fatoumata Daou, Koumba Bagayogo, Yaya Ibrahim Coulibaly, Mahamadou Diakité, Michael P. Fay, Hee‐Suk Lee, Ali Saad, Moez Gribaa, Andrew B. Singleton, Youssoufa Maiga, Sungyoung Auh, Guida Landouré, Rick M. Fairhurst, Barrington G. Burnett, Thomas Scholl & Kenneth H. Fischbeck. (2014) Genetics of low spinal muscular atrophy carrier frequency in sub‐Saharan Africa. Annals of Neurology 75:4, pages 525-532.
Crossref
David J. Wiley, Ilona Juan, Hao Le, Xiaodong Cai, Lisa Baumbach, Christine Beattie & Gennaro D'Urso. (2014) Yeast Augmented Network Analysis (YANA): a new systems approach to identify therapeutic targets for human genetic diseases. F1000Research 3, pages 121.
Crossref
W. David Arnold, Paul N. Porensky, Vicki L. McGovern, Chitra C. Iyer, Sandra Duque, Xiaobai Li, Kathrin Meyer, Leah Schmelzer, Brian K. Kaspar, Stephen J. Kolb, John T. Kissel & Arthur H. M. Burghes. (2013) Electrophysiological biomarkers in spinal muscular atrophy: proof of concept. Annals of Clinical and Translational Neurology 1:1, pages 34-44.
Crossref
Joonbae Seo, Matthew D. Howell, Natalia N. Singh & Ravindra N. Singh. (2013) Spinal muscular atrophy: An update on therapeutic progress. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1832:12, pages 2180-2190.
Crossref
Dian K. Nurputra, Poh San Lai, Nur Imma F. Harahap, Satoru Morikawa, Tomoto Yamamoto, Noriyuki Nishimura, Yuji Kubo, Atsuko Takeuchi, Toshio Saito, Yasuhiro Takeshima, Yumi Tohyama, Stacey KH Tay, Poh Sim Low, Kayoko Saito & Hisahide Nishio. (2013) Spinal Muscular Atrophy: From Gene Discovery to Clinical Trials. Annals of Human Genetics 77:5, pages 435-463.
Crossref
Le Thanh Lam, Heidi R. Fuller & Glenn E. Morris. (2013) The gemin2-binding site on SMN protein: Accessibility to antibody. Biochemical and Biophysical Research Communications 438:4, pages 624-627.
Crossref
W. David Arnold & Arthur H. M. Burghes. (2013) Spinal muscular atrophy: Development and implementation of potential treatments. Annals of Neurology 74:3, pages 348-362.
Crossref
Darrick K. Li, Sarah Tisdale, Jorge Espinoza-Derout, Luciano Saieva, Francesco Lotti & Livio Pellizzoni. (2013) A Cell System for Phenotypic Screening of Modifiers of SMN2 Gene Expression and Function. PLoS ONE 8:8, pages e71965.
Crossref
Benoit B. GouletEmily R. McFallCarmen M. WongRashmi KotharyRobin J. Parks. (2013) Supraphysiological expression of survival motor neuron protein from an adenovirus vector does not adversely affect cell function. Biochemistry and Cell Biology 91:4, pages 252-264.
Crossref
Jonathan J. Cherry, Erkan Y. Osman, Matthew C. Evans, Sungwoon Choi, Xuechao Xing, Gregory D. Cuny, Marcie A. Glicksman, Christian L. Lorson & Elliot J. Androphy. (2013) Enhancement of SMN protein levels in a mouse model of spinal muscular atrophy using novel drug‐like compounds . EMBO Molecular Medicine 5:7, pages 1103-1118.
Crossref
Deborah Y. Kwon, Maria Dimitriadi, Barbara Terzic, Casey Cable, Anne C. Hart, Ajay Chitnis, Kenneth H. Fischbeck & Barrington G. Burnett. (2013) The E3 ubiquitin ligase mind bomb 1 ubiquitinates and promotes the degradation of survival of motor neuron protein. Molecular Biology of the Cell 24:12, pages 1863-1871.
Crossref
Brunhilde Wirth, Lutz Garbes & Markus Riessland. (2013) How genetic modifiers influence the phenotype of spinal muscular atrophy and suggest future therapeutic approaches. Current Opinion in Genetics & Development 23:3, pages 330-338.
Crossref
Reka R. Letso, Andras J. Bauer, Mitchell R. Lunn, Wan Seok Yang & Brent R. Stockwell. (2013) Small Molecule Screen Reveals Regulation of Survival Motor Neuron Protein Abundance by Ras Proteins. ACS Chemical Biology 8:5, pages 914-922.
Crossref
Paul N. PorenskyArthur H.M. Burghes. (2013) Antisense Oligonucleotides for the Treatment of Spinal Muscular Atrophy. Human Gene Therapy 24:5, pages 489-498.
Crossref
Nomazulu Dlamini, Dragana J. Josifova, Simon M.L. Paine, Elizabeth Wraige, Matthew Pitt, Amanda J. Murphy, Andrew King, Stefan Buk, Frances Smith, Stephen Abbs, Caroline Sewry, Thomas S. Jacques & Heinz Jungbluth. (2013) Clinical and neuropathological features of X-linked spinal muscular atrophy (SMAX2) associated with a novel mutation in the UBA1 gene. Neuromuscular Disorders 23:5, pages 391-398.
Crossref
Chalermchai Mitrpant, Paul Porensky, Haiyan Zhou, Loren Price, Francesco Muntoni, Sue Fletcher, Steve D. Wilton & Arthur H. M. Burghes. (2013) Improved Antisense Oligonucleotide Design to Suppress Aberrant SMN2 Gene Transcript Processing: Towards a Treatment for Spinal Muscular Atrophy. PLoS ONE 8:4, pages e62114.
Crossref
Ryan S. Anderton, Bruno P. Meloni, Frank L. Mastaglia & Sherif Boulos. (2013) Spinal Muscular Atrophy and the Antiapoptotic Role of Survival of Motor Neuron (SMN) Protein. Molecular Neurobiology 47:2, pages 821-832.
Crossref
Ke-Jun Han, Daniel G. Foster, Nan-Yan Zhang, Kavdia Kanisha, Monika Dzieciatkowska, Robert A. Sclafani, Kirk C. Hansen, Junmin Peng & Chang-Wei Liu. (2012) Ubiquitin-specific Protease 9x Deubiquitinates and Stabilizes the Spinal Muscular Atrophy Protein-Survival Motor Neuron. Journal of Biological Chemistry 287:52, pages 43741-43752.
Crossref
Renee Martin, Kushol Gupta, Nisha S. Ninan, Kay Perry & Gregory D. Van Duyne. (2012) The Survival Motor Neuron Protein Forms Soluble Glycine Zipper Oligomers. Structure 20:11, pages 1929-1939.
Crossref
Hui-Ling Rose Lee & Joseph P. Dougherty. (2012) Pharmaceutical therapies to recode nonsense mutations in inherited diseases. Pharmacology & Therapeutics 136:2, pages 227-266.
Crossref
Monique A Lorson & Christian L Lorson. (2012) SMN-inducing compounds for the treatment of spinal muscular atrophy. Future Medicinal Chemistry 4:16, pages 2067-2084.
Crossref
Jonathan J CherryElliot J Androphy. (2012) Therapeutic strategies for the treatment of spinal muscular atrophy. Future Medicinal Chemistry 4:13, pages 1733-1750.
Crossref
Virginia B. Mattis, Cheng-Wei Tom Chang & Christian L. Lorson. (2012) Analysis of a read-through promoting compound in a severe mouse model of spinal muscular atrophy. Neuroscience Letters 525:1, pages 72-75.
Crossref
Young-Don Kwak, Bin Wang, Jing Jing Li, Ruishan Wang, Qiyue Deng, Shiyong Diao, Yaomin Chen, Raymond Xu, Eliezer Masliah, Huaxi Xu, Jung-Joon Sung & Francesca-Fang Liao. (2012) Upregulation of the E3 ligase NEDD4-1 by Oxidative Stress Degrades IGF-1 Receptor Protein in Neurodegeneration. The Journal of Neuroscience 32:32, pages 10971-10981.
Crossref
Denise Locatelli, Mineko Terao, Maddalena Fratelli, Adriana Zanetti, Mami Kurosaki, Monica Lupi, Maria Monica Barzago, Andrea Uggetti, Silvia Capra, Paolo D'Errico, Giorgio S. Battaglia & Enrico Garattini. (2012) Human Axonal Survival of Motor Neuron (a-SMN) Protein Stimulates Axon Growth, Cell Motility, C-C Motif Ligand 2 (CCL2), and Insulin-like Growth Factor-1 (IGF1) Production. Journal of Biological Chemistry 287:31, pages 25782-25794.
Crossref
Saif Ahmad, Yi Wang, Gouse M. Shaik, Arthur H. Burghes & Laxman Gangwani. (2012) The zinc finger protein ZPR1 is a potential modifier of spinal muscular atrophy. Human Molecular Genetics 21:12, pages 2745-2758.
Crossref
Ya-Yun Hsu, Yuh-Jyh Jong, Hsin-Hung Tsai, Yu-Ting Tseng, Li-Mei An & Yi-Ching Lo. (2012) Triptolide increases transcript and protein levels of survival motor neurons in human SMA fibroblasts and improves survival in SMA-like mice. British Journal of Pharmacology 166:3, pages 1114-1126.
Crossref
Kavita Praveen, Ying Wen & A. Gregory Matera. (2012) A Drosophila Model of Spinal Muscular Atrophy Uncouples snRNP Biogenesis Functions of Survival Motor Neuron from Locomotion and Viability Defects. Cell Reports 1:6, pages 624-631.
Crossref
Jonathan J. Cherry, Matthew C. Evans, Jake Ni, Gregory D. Cuny, Marcie A. Glicksman & Elliot J. Androphy. (2012) Identification of Novel Compounds That Increase SMN Protein Levels Using an Improved SMN2 Reporter Cell Assay. SLAS Discovery 17:4, pages 481-495.
Crossref
Paul N. Porensky, Chalermchai Mitrpant, Vicki L. McGovern, Adam K. Bevan, Kevin D. Foust, Brain K. Kaspar, Stephen D. Wilton & Arthur H.M. Burghes. (2012) A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse. Human Molecular Genetics 21:7, pages 1625-1638.
Crossref
Indra Sari Kusuma Harahap, Toshio Saito, Lai Poh San, Naoko Sasaki, Gunadi, Dian Kesuma Pramudya Nurputra, Surini Yusoff, Tomoto Yamamoto, Satoru Morikawa, Noriyuki Nishimura, Myeong Jin Lee, Yasuhiro Takeshima, Masafumi Matsuo & Hisahide Nishio. (2012) Valproic acid increases SMN2 expression and modulates SF2/ASF and hnRNPA1 expression in SMA fibroblast cell lines. Brain and Development 34:3, pages 213-222.
Crossref
Benoît Renvoisé, Gwendoline Quérol, Eloi Rémi Verrier, Philippe Burlet & Suzie Lefebvre. (2012) A role for protein phosphatase PP1γ in SMN complex formation and subnuclear localization to Cajal bodies. Journal of Cell Science.
Crossref
Le T Hao, Arthur HM Burghes & Christine E Beattie. (2011) Generation and Characterization of a genetic zebrafish model of SMA carrying the human SMN2gene. Molecular Neurodegeneration 6:1.
Crossref
Deborah Y. Kwon, William W. Motley, Kenneth H. Fischbeck & Barrington G. Burnett. (2011) Increasing expression and decreasing degradation of SMN ameliorate the spinal muscular atrophy phenotype in mice. Human Molecular Genetics 20:18, pages 3667-3677.
Crossref
T. T. Le, V. L. McGovern, I. E. Alwine, X. Wang, A. Massoni-Laporte, M. M. Rich & A. H. M. Burghes. (2011) Temporal requirement for high SMN expression in SMA mice. Human Molecular Genetics 20:18, pages 3578-3591.
Crossref
Chia-Yen Wu, Amelia Curtis, Yong Seok Choi, Miho Maeda, Mary Jue Xu, Amanda Berg, Upasana Joneja, Robert W. Mason, Kelvin H. Lee & Wenlan Wang. (2011) Identification of the phosphorylation sites in the survival motor neuron protein by protein kinase A. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1814:9, pages 1134-1139.
Crossref
Nina R Makhortova, Monica Hayhurst, Antonio Cerqueira, Amy D Sinor-Anderson, Wen-Ning Zhao, Patrick W Heiser, Anthony C Arvanites, Lance S Davidow, Zachary O Waldon, Judith A Steen, Kelvin Lam, Hien D Ngo & Lee L Rubin. (2011) A screen for regulators of survival of motor neuron protein levels. Nature Chemical Biology 7:8, pages 544-552.
Crossref
Tristan H. Coady & Christian L. Lorson. (2011) SMN in spinal muscular atrophy and snRNP biogenesis. Wiley Interdisciplinary Reviews: RNA 2:4, pages 546-564.
Crossref
Jeong Eun Kwon, Eun Kyung Kim & Eui-Ju Choi. (2011) Stabilization of the survival motor neuron protein by ASK1. FEBS Letters 585:9, pages 1287-1292.
Crossref
Claudia Fallini, Honglai Zhang, Yuehang Su, Vincenzo Silani, Robert H. Singer, Wilfried Rossoll & Gary J. Bassell. (2011) The Survival of Motor Neuron (SMN) Protein Interacts with the mRNA-Binding Protein HuD and Regulates Localization of Poly(A) mRNA in Primary Motor Neuron Axons. The Journal of Neuroscience 31:10, pages 3914-3925.
Crossref
Thomas Koed Doktor, Lisbeth Dahl Schroeder, Anne Vested, Johan Palmfeldt, Henriette Skovgaard Andersen, Niels Gregersen & Brage Storstein Andresen. (2011) SMN2 exon 7 splicing is inhibited by binding of hnRNP A1 to a common ESS motif that spans the 3′ splice site. Human Mutation 32:2, pages 220-230.
Crossref
Heidi Fuller, Marija Barišić, Đurđica Šešo-Šimić, Tea Špeljko, Glenn Morris & Goran Šimić. (2010) Treatment strategies for spinal muscular atrophy. Translational Neuroscience 1:4, pages 308-321.
Crossref
Heidi Fuller & Glenn Morris. (2010) SMN complexes of nucleus and cytoplasm: A proteomic study for SMA therapy. Translational Neuroscience 1:4, pages 261-267.
Crossref
Shih-Hsien Hsu, Ming-Chi Lai, Tze-Kiong Er, San-Nan Yang, Chih-Hsing Hung, Hsin-Hung Tsai, Yu-Chieh Lin, Jan-Gowth Chang, Yi-Ching Lo & Yuh-Jyh Jong. (2010) Ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) regulates the level of SMN expression through ubiquitination in primary spinal muscular atrophy fibroblasts. Clinica Chimica Acta 411:23-24, pages 1920-1928.
Crossref
Adam K. Bevan, Kirk R. Hutchinson, Kevin D. Foust, Lyndsey Braun, Vicki L. McGovern, Leah Schmelzer, Jennifer G. Ward, Jeffrey C. Petruska, Pamela A. Lucchesi, Arthur H.M. Burghes & Brian K. Kaspar. (2010) Early heart failure in the SMNΔ7 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery. Human Molecular Genetics 19:20, pages 3895-3905.
Crossref
Claribel D Wee, Lingling Kong & Charlotte J Sumner. (2010) The genetics of spinal muscular atrophies. Current Opinion in Neurology 23:5, pages 450-458.
Crossref
Arthur H.M. Burghes & Vicki L. McGovern. (2010) Antisense oligonucleotides and spinal muscular atrophy: skipping along: Figure 1.. Genes & Development 24:15, pages 1574-1579.
Crossref

Displaying 200 of 209 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.